Immunoglobulin Market to Surpass US$ 20.1 Billion at a CAGR of 6.34% by 2027

PRESS RELEASE

Published March 10, 2023

IMARC Group has recently released a new research study titled “Immunoglobulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global immunoglobulin market size reached US$ 13.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 20.1 Billion by 2027, exhibiting a growth rate (CAGR) of 6.34% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Immunoglobulins, also known as antibodies, are glycoprotein molecules formed by plasma cells or white blood cells (WBCs). They help identify and bind foreign antigens, such as viruses or bacteria and prevent the spread of infections to other parts of the body. As a result, they are used in the treatment of various neurological and immunological diseases worldwide.

Request for a free sample copy of this report: https://www.imarcgroup.com/immunoglobulin-market/requestsample

Immunoglobulin Market Trends and Drivers:

The increasing consumption of ready-to-eat (RTE) food products is leading to numerous medical conditions around the world. This, in confluence with the proven efficiency of immunoglobulins as an effective treatment for immune disorders, is positively influencing the market. Besides this, the growing geriatric population, which is more susceptible to chronic medical ailments like myeloma, is acting as another growth-inducing factor. Furthermore, technological advancements in purification techniques are creating a positive outlook for the market. Moreover, numerous research and development (R&D) activities by medical researchers to develop advanced and effective products are expected to drive the market.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

Breakup by Application:

Hypogammaglobulinemia
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Immunodeficiency Disease
Myasthenia Gravis
Others

Breakup by Mode of Delivery:

Intravenous Mode of Delivery
Subcutaneous Mode of Delivery

Market Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Competitive Landscape with Key Player:

ADMA Biologics Inc.
Baxter international Inc.
Biotest AG
CSL Limited
Grifols S.A
Kedrion S.p.A
LFB SA
Octapharma AG
Sanquin Plasma Products B.V.
Takeda Pharmaceutical Company Limited.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=4505&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA